Effects of supplementation with curcuminoids on serum copper and zinc concentrations and superoxide dismutase enzyme activity in obese subjects

Trace Elements and Electrolytes

Volumn 32, Issue 1, 2014, Pages 16-21

  Mohajer, Afsaneh ^a   Ghayour Mobarhan, Majid ^a,b   Parizadeh, Seyed Mohammad Reza ^a   Tavallaie, Shima ^a   Rajabian, Majid ^a   Sahebkar, Amirhossein ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Copper; Diferuloylmethane; Superoxide dismutase; Zinc

Indexed keywords

ANTIOXIDANT; COPPER; CURCUMIN; CURCUMINOID; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; PIPERINE; PLACEBO; POLYPHENOL DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ZINC;

ADJUVANT THERAPY; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME ACTIVITY; HEART PROTECTION; HUMAN; OBESITY; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; TREATMENT DURATION; ZINC BLOOD LEVEL;

EID: 84914810399     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: 10.5414/TEX01363     Document Type: Article

References (48)

1. Bravo PE, Morse S, Borne DM, Aguilar EA, Reisin E. Leptin and hypertension in obesity. Vasc Health Risk Manag. 2006; 2: 163-169. CrossRef PubMed
2. Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, Esquivel-Soto J, Morales-González A, Esquivel-Chirino C, Durante-Montiel I, Sánchez-Rivera G, Valadez-Vega C, Morales-González JA. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011; 12: 3117-3132. CrossRef PubMed
3. Ferns GAA, Lamb DJ, Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis. 1997; 133: 139-152. CrossRef PubMed
4. Yerlikaya FH, Toker A, Aribaş A. Serum trace elements in obese women with or without diabetes. Indian J Med Res. 2013; 137: 339-345. PubMed
5. Milbury PE, Richer AC. Understanding the antioxidant controversy: Scrutinizing the "fountain of youth". Greenwood Publishing Group 99. 2008.
6. Araya M, Pizarro F, Olivares M, Arredondo M, González M, Méndez M. Understanding copper homeostasis in humans and copper effects on health. Biol Res. 2006; 39: 183-187. CrossRef PubMed
7. Khan NI, Naz L, Yasmeen G. Obesity: an independent risk factor for systemic oxidative stress. Pak J Pharm Sci. 2006; 19: 62-65. PubMed
8. Amirkhizi F, Siassi F, Minaie S, Djalali M, Rahimi A, Chamari M. Is obesity associated with increased plasma lipid peroxidacion and oxidative stress in women. Arya Atheroscler J. 2007; 2: 189-192.
9. Harris ED. Copper homeostasis: the role of cellular transporters. Nutr Rev. 2001; 59: 281-285. CrossRef PubMed
10. Osredkar J, Sustar N. Copper and zinc, biological role and significance of copper/zinc imbalance. J Clinic Toxicol. 2011; S3: 001.
11. Calixto JB, Otuki MF, Santos AR. Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NF-kappaB). Planta Med. 2003; 69: 973-983. CrossRef PubMed
12. Sahebkar A. Molecular mechanisms for curcumin benefits against ischemic injury. Fertil Steril. 2010; 94: e75-e76., author reply e77 PubMed
13. Sahebkar A. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? Biofactors. 2013; 39: 197-208. CrossRef PubMed
14. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res. 2014; 28: 633-642. PubMed
15. Gupta SC, Kismali G, Aggarwal BB. Curcumin, a component of turmeric: from farm to pharmacy. Biofactors. 2013; 39: 2-13. CrossRef PubMed
16. Strimpakos AS, Sharma RA. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal. 2008; 10: 511-545. CrossRef PubMed
17. Sahebkar A. Curcuminoids for the management of hypertriglyceridaemia. Nat Rev Cardiol. 2014; 11: 123 CrossRef PubMed
18. Panahi Y, Saadat A, Beiraghdar F, Sahebkar A. Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: A randomized double-blind placebo-controlled trial. Phytother Res. 2014; doi: 10.1002/ptr.5149 (Epub ahead of print). CrossRef PubMed
19. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013; 15: 195-218. CrossRef PubMed
20. Mohammadi A, Sahebkar A, Iranshahi M, Amini M, Khojasteh R, Ghayour-Mobarhan M, Ferns GA. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytother Res. 2013; 27: 374-379. CrossRef PubMed
21. Sahebkar A. Low-density lipoprotein is a potential target for curcumin: novel mechanistic insights. Basic Clin Pharmacol Toxicol. 2014; 114: 437-438. CrossRef PubMed
22. Panahi Y, Sahebkar A, Parvin S, Saadat A. A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Ann Clin Biochem. 2012; 49: 580-588. CrossRef PubMed
23. Ak T, Gülc¸in I. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact. 2008; 174: 27-37. CrossRef PubMed
24. Masuda T, Maekawa T, Hidaka K, Bando H, Takeda Y, Yamaguchi H. Chemical studies on antioxidant mechanism of curcumin: analysis of oxidative coupling products from curcumin and linoleate. J Agric Food Chem. 2001; 49: 2539-2547. CrossRef PubMed
25. Sahebkar A, Mohammadi A, Atabati A, Rahiman S, Tavallaie S, Iranshahi M, Akhlaghi S, Ferns GA, Ghayour-Mobarhan M. Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytother Res. 2013; 27: 1883-1888. CrossRef PubMed
26. Panahi Y, Saadat A, Beiraghdar F, Hosseini Nouzari SM, Jalalian HR, Sahebkar A. Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: A randomized double-blind placebo-controlled trial. J Funct Foods. 2014; 6: 615-622. CrossRef
27. Panahi Y, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, Kolivand M. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2012; 108: 1272-1279. CrossRef PubMed
28. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998; 64: 353-356. CrossRef PubMed
29. Kaplan A. Clin Chem. Mosby Co. St Louis. Toronto. Princeton 1984.
30. Ahmed H, Schott EJ, Gauthier JD, Vasta GR. Superoxide dismutases from the oyster parasite Perkinsus marinus: purification, biochemical characterization, and development of a plate microassay for activity. Anal Biochem. 2003; 318: 132-141. CrossRef PubMed
31. DiSilvestro RA, Joseph E, Zhao S, Bomser J. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J. 2012; 11: 79. CrossRef PubMed
32. Kalpravidh RW, Siritanaratkul N, Insain P, Charoensakdi R, Panichkul N, Hatairaktham S, Srichairatanakool S, Phisalaphong C, Rachmilewitz E, Fucharoen S. Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids. Clin Biochem. 2010; 43: 424-429. CrossRef PubMed
33. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352: 1685-1695. CrossRef PubMed
34. Klotz LO, Kröncke KD, Buchczyk DP, Sies H. Role of copper, zinc, selenium and tellurium in the cellular defense against oxidative and nitrosative stress. J Nutr. 2003; 133 (Suppl 1): 1448S-1451S. PubMed
35. Lima SC, Arrais RF, Sales CH, Almeida MG, de Sena KC, Oliveira VT, de Andrade AS, Pedrosa LF. Assessment of copper and lipid profile in obese children and adolescents. Biol Trace Elem Res. 2006; 114: 19-29. CrossRef PubMed
36. Ford ES. Serum copper concentration and coronary heart disease among US adults. Am J Epidemiol. 2000; 151: 1182-1188. CrossRef PubMed
37. Kinlaw WB, Levine AS, Morley JE, Silvis SE, Mc-Clain CJ. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med. 1983; 75: 273-277. CrossRef PubMed
38. Klevay LM. Cardiovascular disease from copper deficiency - a history. J Nutr. 2000; 130 (2S Suppl): 489S-492S. PubMed
39. Allen KGD, Klevay LM. Cholesterolemia and cardiovascular abnormalities in rats caused by copper deficiency. Atherosclerosis. 1978; 29: 81-93. CrossRef PubMed
40. Costarelli L, Muti E, Malavolta M, Cipriano C, Giacconi R, Tesei S, Piacenza F, Pierpaoli S, Gasparini N, Faloia E, Tirabassi G, Boscaro M, Polito A, Mauro B, Maiani F, Raguzzini A, Marcellini F, Giuli C, Papa R, Emanuelli M, et al. Distinctive modulation of inflammatory and metabolic parameters in relation to zinc nutritional status in adult overweight/obese subjects. J Nutr Biochem. 2010; 21: 432-437. CrossRef PubMed
41. Klevay LM. Bariatric surgery and the assessment of copper and zinc nutriture. Obes Surg. 2010; 20: 672-673., author reply 674-675. CrossRef PubMed
42. Dambal SS, Indumati V, Kumari S. Relationship of obesity with micronutrient status. IJABPT. 2011; 2: 280-284.
43. Egefjord L, Jensen JL, Bang-Berthelsen CH, Petersen AB, Smidt K, Schmitz O, Karlsen AE, Pociot F, Chimienti F, Rungby J, Magnusson NE. Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis? BMC Endocr Disord. 2009; 9: 7. CrossRef PubMed
44. Foster M, Samman S. Zinc and atherosclerosis: clinical observations and potential mechanisms. In: Zinc and human health. Biomedical and Health Research. 2012; 76: 347372.
45. Babu PS, Srinivasan K. Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem. 1995; 152: 13-21. PubMed
46. Panahi Y, Badeli R, Karami N, Sahebkar A. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytother Res. 2014; epub ahead of print. PubMed
47. Panahi Y, Khalili N, Hosseini MS, Abbasinazari M, Sahebkar A. Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial. Complement Ther Med. 2014. Epub ahead of print.
48. Panahi Y, Rahimnia A, Sharafi M, Alishiri G, Saburi A, Sahebkar A. Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytother Res. 2014. Epub ahead of print. PubMed